Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-039697 General Corporate
Debt relative to revenue 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
127.69% · OPTIONAL · VALID
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.26% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.10% · OPTIONAL · VALID
Revenue growth 16th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
-15.75% · CORE · VALID
Inventory pressure 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
61.16% · OPTIONAL · VALID
Gross margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
23.04% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.50% · CORE · VALID
R&D intensity 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.55% · OPTIONAL · VALID
SBC intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.31% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 131.66%
Current 127.69%
Delta -3.97% Capex Intensity Increased
Previous 4.94%
Current 8.26%
Delta 3.33% Cash Generation Increased
Previous 15.68%
Current 25.10%
Delta 9.42% Growth Decreased
Previous -5.40%
Current -15.75%
Delta -10.35% Inventory Pressure Increased
Previous 60.50%
Current 61.16%
Delta 0.65% Margin Increased
Previous 20.33%
Current 23.04%
Delta 2.71% Profitability Increased
Previous 12.49%
Current 15.50%
Delta 3.01% R And D Intensity Increased
Previous 1.45%
Current 1.55%
Delta 0.10% Sbc Intensity Decreased
Previous 0.58%
Current 0.31%
Delta -0.27% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.